Clinical Agents Repository Inventory Management System (CARIM)

Business Need
The National Institute of Allergy and Infectious Diseases (NIAID) Division of Microbiology and Infectious Diseases (DMID) supports research in many areas including bacteriology and mycology, biodefense, emerging infectious diseases, microbial genomics, parasitology, respiratory diseases, sexually transmitted infections, vaccine development, and virology that has improved the health of millions of people in the United States and around the world. DMID recognized that manually managing the inventory, control, and delivery of hundreds of investigational new drugs was not only cumbersome but also time consuming.

Solution
CTi developed a customized web-based application, the Clinical Agents Repository Inventory Management System (CARIM), to effectively manage and control the inventory of the new investigational drugs. The web-based solution allowed DMID to automate and enforce its complex business processes of storing, shipping, receiving, and categorizing investigational new drugs within a secure environment.

Results
DMID can monitor and track investigational new drugs that represent potential future treatment options in the control and prevention of human disease, including, but not limited to; small pox, influenza, antimicrobial resistance, viral infections, and biodefense-related diseases. CARIM also allows DMID to ensure the integrity and security of these substances pending FDA approval.